MEDEZE.BK Medeze Group PCL

Healthcare Medical Care Facilities Thailand Exchange
5.60 THB
Close of Nov 7, 2026
5.60 7.25
Market cap
THB 5.98B
P/E
46.7x
P/B
2.03x
ROE
5.1%
Dividend yield
2.86%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MEDEZE.BK undervalued?

Graham number
Price5.60
Graham value2.73
Premium105.2%

MEDEZE.BK trades 105.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medeze Group PCL fundamental analysis

No fundamental analysis for Medeze Group PCL yet.

Medeze Group PCL stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medeze Group PCL

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in r…

Full company profile